Cladis Investment Advisory LLC Boosts Position in iShares Biotechnology ETF (NASDAQ:IBB)

Cladis Investment Advisory LLC lifted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 41.7% in the third quarter, Holdings Channel.com reports. The fund owned 4,300 shares of the financial services provider’s stock after purchasing an additional 1,265 shares during the period. Cladis Investment Advisory LLC’s holdings in iShares Biotechnology ETF were worth $626,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Arrowroot Family Office LLC lifted its holdings in iShares Biotechnology ETF by 37.5% in the third quarter. Arrowroot Family Office LLC now owns 7,041 shares of the financial services provider’s stock worth $1,025,000 after buying an additional 1,921 shares during the period. Benjamin Edwards Inc. bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $244,000. Alerus Financial NA purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $205,000. FSA Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $65,000. Finally, Erste Asset Management GmbH purchased a new stake in iShares Biotechnology ETF in the third quarter worth $5,678,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.0 %

IBB opened at $141.55 on Monday. The stock has a fifty day simple moving average of $142.71 and a two-hundred day simple moving average of $142.06. iShares Biotechnology ETF has a 12-month low of $119.95 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.